Recent developments in understanding the mechanism of vitamin K and vitamin K-antagonist drug action and the consequences of vitamin K action in blood coagulation.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Progress in hematology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 337364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The role of fat-soluble vitamins on bone metabolism and osteoporosis: a literature review

  2025cites this paper
• In silico toxicity investigation of Methaqualone’s conjunctival, retinal, and gastrointestinal hemorrhage by molecular modelling approach

  2022cites this paper
• Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters

  2021cites this paper
• Pharmacogenomics

  2019cites this paper
• Personalized medicine: Genetic risk prediction of drug response

  2017cites this paper
• Chapter 18 – Superwarfarins

  2015cites this paper
• Chapter 56 – Anticoagulant rodenticides

  2012cites this paper
• Biochemistry of Hemostasis

  2011cites this paper
• A CASE OF ACUTE CHOLECYSTITIS WITH HYPOCOAGULABILITY DUE TO ANTIBIOTICS TREATMENT IN AN NPO PATIENT

  2009cites this paper
• CHAPTER 48 – Anticoagulant rodenticides

  2007cites this paper
• Table 2 . Analytical Recovery of Purifled Factor X in Factor-X Deficient Plasma Factor

  2004cites this paper
• A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy

  2003cites this paper
• State-of-the-Art Review: Pharmacology and Pharmacokinetics of Antithrombotic Agents

  1997cites this paper
• Effects of vitamin K2 on blood coagulation in surgical patients with antibiotics

  1989cites this paper
• Effects of sodium ascorbate (vitamin C) and 2‐methyl‐1,4‐naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action

  1989cites this paper
• The Bioavailability of a Mixed Micellar Preparation of Vitamin K1, and its Procoagulant Effect in Anticoagulated Rabbits

  1989cites this paper
• An investigation of the pharmacological response to vitamin K1 in the rabbit

  1988cites this paper
• Relation entre la cinétique et l'efficacité de la bromadiolone chez Rattus norvegicus sauvage1

  1988cites this paper
• Coagulation Defects of Aflatoxin Intoxicated Rabbits

  1987cites this paper
• Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors.

  1986cites this paper
• Mechanism of Action and Monitoring of Anticoagulants

  1986cites this paper
• Modern antithrombotic agents (survey)

  1985cites this paper
• A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.

  1985cites this paper
• Changes of plasma protein C levels in liver diseases

  1985cites this paper
• Gerinnungsstörungen im Schock

  1984cites this paper
• Inhibition of monocyte chemotaxis by vitamins in vitro

  1984cites this paper
• DiagnosticEfficacyof Newer Synthetic-SubstratesMethodsfor Assessing CoagulationVariables:A Critical Overview

  1983cites this paper
• Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.

  1983cites this paper
• Recent apects on platelets

  1983cites this paper
• Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay.

  1983cites this paper
• Synthetic peptide substrates in hemostatic testing.

  1983cites this paper
• Prothrombin antigen and coagulant activity in patients with liver disease.

  1982cites this paper
• THROMBIN SPECIFICITY *

  1981cites this paper
• Hemoglobin concentration of children with sickle cell trait.

  1981cites this paper
• The vitamin K-dependent proteins.

  1981cites this paper
• Vitamin K3 (menadione) inhibits the growth of mammalian tumor cells in culture.

  1981cites this paper
• Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency.

  1981cites this paper
• Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis.

  1981cites this paper
• Mechanized Amidolytic Technique forDetermination of FactorX and Factor-XAntigen, andItsApplication to Patients BeingTreatedwithOral Anticoagulants

  1980cites this paper
• Mechanism Of Action Of Vitamin K: Synthesis Of Y-Carboxyglutamic Aci

  1980cites this paper
• Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.

  1980cites this paper
• Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid.

  1980cites this paper
• Factor II (prothrombin) levels in cord blood: correlation of coagulant activity with immunoreactive protein.

  1980cites this paper
• Combined functional and immunochemical analysis of normal and abnormal human factor X.

  1979cites this paper
• Fibrinogen synthesis in serum-free hepatocyte cultures: stimulation by glucocorticoids.

  1978cites this paper